“clinical-trials” Archives

in
Entry Author Date Location
Portola Pharmaceuticals’ Drug to Prevent Blood Clots Wins FDA Nod 06/23/17 San Francisco
Syntimmune Snares $50M to Test Autoimmune Drug in Two Rare Diseases 06/21/17 New York
With $23M, Flagship-Backed Sigilon Protects Protein-Producing Cells 06/21/17 Boston
Rubius Adds $120M to Ready Tests of Red Blood Cells as Drug Carriers 06/21/17 Boston
Checkmate Pharma Clinches $27M for More Studies in Skin Cancer 06/15/17 Boston
UT Health Cancer Center Hires Rare Blood Cancer Expert as Director 06/15/17 Texas
Athenex IPO Raises $66M to Fund Clinical Trials for Cancer Drugs 06/14/17 New York
In a Myeloma Setback, Merck Halts Studies Due to Patient Deaths 06/12/17 New York
Regulus Dumps Two Drugs, AstraZeneca Sends Back Another, Shares Fall 06/12/17 San Diego
Exact, WARF, Murfie, Microbes, & More: This Week’s WI Watchlist 06/09/17 Wisconsin
Stratatech Starts Latest Study of Skin-Like Tissue in Burn Patients 06/09/17 Wisconsin
Eli Lilly Fronts $55M for Rights to KeyBioscience’s Diabetes Drugs 06/08/17 Indiana
Harvard Biotech Spinout Lands $10M to Make Platelets From Stem Cells 06/08/17 Boston
Facing Cash Crunch, Novan Slashes Staff and Shuffles Executive Team 06/05/17 Raleigh Durham
Precision Steps: Can Loxo Drug Help Broaden Use of Cancer DNA Tests? 06/03/17 National
Endocyte Cuts Workforce by 40 Percent After Clinical Trial Falters 06/02/17 Indiana
Mersana Plans IPO to Finance Clinical Trials for Breast Cancer Drug 06/02/17 Boston
Array Lands $31M in Licensing Deal with Japan’s Ono Pharma 06/01/17 Boulder/Denver
Bicycle Therapeutics Maps Course to Clinic Backed by $52M Investment 06/01/17 Boston
Teva Seeks to Keep Pace in Migraine Drug Race With Trial Results 05/31/17 New York
Woodcock: New Approvals Show FDA Is Adapting to Precision Medicine 05/30/17 National
Protagonist, Janssen Ink Development Deal for Crohn’s Disease Drug 05/30/17 San Francisco
On ASCO’s Eve, Experts Fret Over Backlash to Cancer Combo Frenzy 05/30/17 National
Unconventional Partners, Like FDA, Can Drive Adoption of New Tech 05/24/17 Boston
FDA Landmark Nod: Cancer Drug To Match Tumor Genes, Not Tissue Type 05/23/17 National
ViaCyte Raises $10M, Moves to Human Trial with New Diabetes Product 05/23/17 San Diego
Celgene’s Data Could Lead To New Option For Multiple Sclerosis Patients 05/22/17 New York
Radius Shares Jump as Amgen’s Bone Drug Suffers a Setback in Phase 3 05/22/17 San Francisco
Ex-Sarepta CEO Garabedian Returns to Run Bio Accelerator Xontogeny 05/18/17 Boston
Riding Recent Biotech IPO Wave, G1 Snags $105M to Fund Cancer Work 05/17/17 Raleigh Durham
Page 1 of 25 next page »